https://medicaex.com/businesswire/saudi-arabia-diagnostic-imaging-x-ray-imaging-solutions-ultrasound-mri-ct-nuclear-imaging-solutions-mammography-markets-analysis-competition-forecast-opportunities-2017-2022-202/ 2022-11-03T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-mfKIv3.jpeg https://medicaex.com/businesswire/novadip-biosciences-raises-additional-eur-40-million-bringing-total-company-funding-to-eur-88-million-2/ 2022-11-03T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/191016_Novadip_Logo_horizontal_RGB_Large-aes1R1.jpeg https://medicaex.com/businesswire/global-digital-diabetes-management-market-report-to-2027-increasing-diabetes-related-health-expenditure-presents-opportunities-researchandmarkets-com/ 2022-11-03T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-jUzHjj.jpeg https://medicaex.com/businesswire/novadip-biosciences-raises-additional-eur-40-million-bringing-total-company-funding-to-eur-88-million/ 2022-11-03T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/191016_Novadip_Logo_horizontal_RGB_Large-RyKsUT.jpeg https://medicaex.com/businesswire/avencell-to-present-new-data-from-lead-universal-car-t-cell-therapy-program-at-64th-american-society-of-hematology-annual-meeting-and-exposition/ 2022-11-03T18:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Avencell-HighRes_colour-r8W8vW.jpeg https://medicaex.com/businesswire/presentations-on-ropeginterferon-alfa-2b-during-ash-annual-meeting-highlight-momentum-in-the-care-of-polycythemia-vera/ 2022-11-03T18:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-pharma-essentia-vLmLGA.jpeg https://medicaex.com/businesswire/h-i-g-capital-completes-acquisition-of-celerion/ 2022-11-03T18:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/New_HIGCapital-oI5cEK.jpeg https://medicaex.com/businesswire/global-facial-injectables-market-report-2022-continuous-introduction-of-new-products-aids-sector-growth-researchandmarkets-com/ 2022-11-03T18:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-yBjnaQ.jpeg https://medicaex.com/businesswire/twist-bioscience-to-report-fiscal-2022-fourth-quarter-and-full-year-financial-results-on-friday-november-18-2022/ 2022-11-03T18:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Twist_Bioscience_Logo-C7VPvY.jpeg https://medicaex.com/businesswire/aim-immunotech-shareholders-elect-all-three-company-director-nominees-at-2022-annual-meeting-2/ 2022-11-03T17:12:13+00:00 https://medicaex.com/businesswire/global-external-urine-management-products-market-report-2022-rising-rates-of-incontinence-driving-sector-growth-researchandmarkets-com-3/ 2022-11-03T17:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-gNgu24.jpeg https://medicaex.com/businesswire/maat-pharma-announces-oral-and-poster-presentations-at-the-64th-american-society-of-hematology-ash-annual-meeting-2/ 2022-11-03T17:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nov_2018_new_version_MaaT_Pharma_logo-znBg9F.jpeg https://medicaex.com/businesswire/consortium-of-health-care-organizations-announces-establishment-of-project-clarity-a-cross-industry-workgroup-to-expand-use-of-price-transparency-information/ 2022-11-03T17:12:10+00:00 https://medicaex.com/businesswire/endologix-reports-five-year-data-of-the-leopard-trial-at-2022-vascular-interventional-advances-viva-conference/ 2022-11-03T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_endo-HWL8m9.jpeg https://medicaex.com/businesswire/integrated-endoscopy-announces-the-global-launch-of-gen-ii-nuvis-single-use-4k-battery-operated-cordless-arthroscope/ 2022-11-03T17:12:08+00:00 https://medicaex.com/businesswire/global-external-urine-management-products-market-report-2022-rising-rates-of-incontinence-driving-sector-growth-researchandmarkets-com-2/ 2022-11-03T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-LpaWKm.jpeg https://medicaex.com/businesswire/global-external-urine-management-products-market-report-2022-rising-rates-of-incontinence-driving-sector-growth-researchandmarkets-com/ 2022-11-03T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-YU2Pn1.jpeg https://medicaex.com/businesswire/maat-pharma-announces-oral-and-poster-presentations-at-the-64th-american-society-of-hematology-ash-annual-meeting/ 2022-11-03T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nov_2018_new_version_MaaT_Pharma_logo-HRz8mH.jpeg https://medicaex.com/businesswire/aim-immunotech-shareholders-elect-all-three-company-director-nominees-at-2022-annual-meeting/ 2022-11-03T17:12:04+00:00 https://medicaex.com/businesswire/global-3d-printed-drugs-market-report-2022-drawbacks-of-traditional-pharmaceutical-operations-fueling-growth-researchandmarkets-com/ 2022-11-03T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-PgY0jx.jpeg https://medicaex.com/businesswire/weave-adds-od-link-integration-for-vision-care-professionals/ 2022-11-03T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/weave-odlink-post-image-VkIoh1.jpeg https://medicaex.com/businesswire/tele-intensive-care-unit-global-market-report-2022-increase-in-icu-admission-rates-high-adoption-of-tele-icus-driving-growth-researchandmarkets-com-4/ 2022-11-03T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-cv2tXN.jpeg https://medicaex.com/businesswire/tele-intensive-care-unit-global-market-report-2022-increase-in-icu-admission-rates-high-adoption-of-tele-icus-driving-growth-researchandmarkets-com-3/ 2022-11-03T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-oW22Te.jpeg https://medicaex.com/businesswire/atacor-medical-to-present-acute-and-3-month-results-from-extravascular-implantable-cardioverter-defibrillator-ev-icd-studies/ 2022-11-03T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/AtaCorMedical-ZqT31Z.jpeg https://medicaex.com/businesswire/tele-intensive-care-unit-global-market-report-2022-increase-in-icu-admission-rates-high-adoption-of-tele-icus-driving-growth-researchandmarkets-com-2/ 2022-11-03T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-xWTSCR.jpeg https://medicaex.com/businesswire/tele-intensive-care-unit-global-market-report-2022-increase-in-icu-admission-rates-high-adoption-of-tele-icus-driving-growth-researchandmarkets-com/ 2022-11-03T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-GSqBir.jpeg https://medicaex.com/businesswire/more-than-50-abstracts-from-incytes-robust-oncology-portfolio-to-be-featured-at-the-64th-ash-annual-meeting-2/ 2022-11-03T15:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Incyte_Color_Logo_JPEG_282_Color_Positive29-U6X5FK.jpeg https://medicaex.com/businesswire/stephen-fisher-md-chief-medical-officer-and-special-advisor-at-chesapeake-employers-insurance-company-joins-harvard-medtechs-medical-advisory-board-3/ 2022-11-03T15:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-gVGPwv.jpeg https://medicaex.com/businesswire/global-clinical-grade-wearables-market-analysis-report-2022-2026-customizable-service-based-solutions-and-platforms-presents-opportunities-researchandmarkets-com/ 2022-11-03T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-oQRyqK.jpeg https://medicaex.com/businesswire/stephen-fisher-md-chief-medical-officer-and-special-advisor-at-chesapeake-employers-insurance-company-joins-harvard-medtechs-medical-advisory-board-2/ 2022-11-03T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-OCVLfb.jpeg https://medicaex.com/businesswire/eco-healthtech-apparel-brand-swiss-precision-launches-startengine-crowdfunding-campaign/ 2022-11-03T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/IG-68-min-819x1024-J0jVwn.jpeg https://medicaex.com/businesswire/more-than-50-abstracts-from-incytes-robust-oncology-portfolio-to-be-featured-at-the-64th-ash-annual-meeting/ 2022-11-03T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Incyte_Color_Logo_JPEG_282_Color_Positive29-DibAba.jpeg https://medicaex.com/businesswire/stephen-fisher-md-chief-medical-officer-and-special-advisor-at-chesapeake-employers-insurance-company-joins-harvard-medtechs-medical-advisory-board/ 2022-11-03T15:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-6hGayQ.jpeg https://medicaex.com/businesswire/ai-proteins-secures-18-2-million-seed-round-to-pioneer-high-throughput-platform-for-advanced-miniprotein-therapeutics-2/ 2022-11-03T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/aiProteins_Final_logoWText-BtpK33.jpeg https://medicaex.com/businesswire/kezar-life-sciences-presents-positive-complete-results-from-the-mission-phase-2-trial-evaluating-zetomipzomib-in-lupus-nephritis-at-asns-kidney-week-2022-annual-meeting-2/ 2022-11-03T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Kezar_Life_Sciences_logo_July_2022-8LlNdX.jpeg https://medicaex.com/businesswire/valenzabio-announces-positive-preliminary-data-from-phase-1b-2a-trial-of-vb119-an-anti-cd19-monoclonal-antibody-for-the-treatment-of-primary-membranous-nephropathy-2/ 2022-11-03T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-38wi7r.jpeg https://medicaex.com/businesswire/laurent-pharmaceuticals-presents-results-from-phase-2-clinical-study-of-lau-7b-in-cystic-fibrosis-at-the-nacfc-2022-2/ 2022-11-03T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/NEW_LOGO_Laurent-Pharma-J7gNKd.jpeg https://medicaex.com/businesswire/annual-holdem-for-life-charity-challenge-sets-a-new-record/ 2022-11-03T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/DiamondCorp_Logo-Yps77m.jpeg https://medicaex.com/businesswire/schrodinger-to-present-new-preclinical-data-from-its-cdc7-inhibitor-program-at-american-society-of-hematology-2022-annual-meeting/ 2022-11-03T14:12:13+00:00 https://medicaex.com/businesswire/welldoc-chief-analytics-officer-anand-iyer-phd-mba-receives-global-innovator-award-at-international-summit-focused-on-digital-health/ 2022-11-03T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Welldoc_logo-JrToD9.jpeg https://medicaex.com/businesswire/eight-sleep-hires-former-peloton-global-chief-sales-officer-tim-shannehan-as-new-chief-revenue-officer/ 2022-11-03T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pod_Lifestyle-foKnDw.jpeg https://medicaex.com/businesswire/global-hearing-amplifiers-market-report-2022-increasing-government-initiatives-to-combat-deafness-driving-growth-researchandmarkets-com/ 2022-11-03T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-7oBliR.jpeg https://medicaex.com/businesswire/the-worldwide-growth-stimulator-industry-is-expected-to-reach-1-8-billion-by-2027-researchandmarkets-com/ 2022-11-03T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-EmN1su.jpeg https://medicaex.com/businesswire/tempus-launches-first-cardiology-prospective-study-for-its-ai-enabled-predictive-tests-2/ 2022-11-03T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/black_wordmark-WNBIDl.jpeg https://medicaex.com/businesswire/tempus-launches-first-cardiology-prospective-study-for-its-ai-enabled-predictive-tests/ 2022-11-03T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/black_wordmark-ULfUZE.jpeg https://medicaex.com/businesswire/kezar-life-sciences-presents-positive-complete-results-from-the-mission-phase-2-trial-evaluating-zetomipzomib-in-lupus-nephritis-at-asns-kidney-week-2022-annual-meeting/ 2022-11-03T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Kezar_Life_Sciences_logo_July_2022-gZNMyc.jpeg https://medicaex.com/businesswire/valenzabio-announces-positive-preliminary-data-from-phase-1b-2a-trial-of-vb119-an-anti-cd19-monoclonal-antibody-for-the-treatment-of-primary-membranous-nephropathy/ 2022-11-03T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-TgNmPN.jpeg https://medicaex.com/businesswire/laurent-pharmaceuticals-presents-results-from-phase-2-clinical-study-of-lau-7b-in-cystic-fibrosis-at-the-nacfc-2022/ 2022-11-03T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/NEW_LOGO_Laurent-Pharma-ju0pJK.jpeg https://medicaex.com/businesswire/axcella-to-present-at-the-american-association-for-the-study-of-liver-diseases-aasld-annual-meeting/ 2022-11-03T14:12:06+00:00 https://medicaex.com/businesswire/ai-proteins-secures-18-2-million-seed-round-to-pioneer-high-throughput-platform-for-advanced-miniprotein-therapeutics/ 2022-11-03T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/aiProteins_Final_logoWText-xLQERH.jpeg https://medicaex.com/businesswire/pfizers-elranatamab-granted-fda-breakthrough-therapy-designation-for-relapsed-or-refractory-multiple-myeloma-3/ 2022-11-03T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pfizer_Logo_Color_RGB_APPROVED-qi5bgQ.jpeg https://medicaex.com/businesswire/final-data-from-allovirs-phase-2-study-of-posoleucel-for-multi-virus-prevention-to-be-highlighted-in-oral-presentation-at-64th-american-society-of-hematology-annual-meeting-2/ 2022-11-03T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/AlloVir_Logo_FullColor5B25D-qIGQev.jpeg https://medicaex.com/businesswire/gamida-cell-announces-omidubicel-data-to-be-presented-as-an-oral-presentation-at-64th-ash-annual-meeting-2/ 2022-11-03T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gamida-Cell-Logo_Sept2022-KrWC0Z.jpeg https://medicaex.com/businesswire/2seventy-bio-to-present-data-from-karmma-2-study-of-abecma-idecabtagene-vicleucel-at-the-64th-american-society-of-hematology-ash-annual-meeting-and-exposition-2/ 2022-11-03T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/2seventy_logo_for_BW-Z5SBCB.jpeg https://medicaex.com/businesswire/graphite-bio-announces-abstracts-accepted-for-upcoming-64th-ash-annual-meeting-and-exposition/ 2022-11-03T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Graphite_Bio_Primary_Logo_RGB_M01-3Mssly.jpeg https://medicaex.com/businesswire/amwell-announces-appointment-of-robert-webb-to-its-board-of-directors/ 2022-11-03T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/amwell_logo-6DI5gG.jpeg https://medicaex.com/businesswire/acos-using-caresignals-deviceless-rpm-solution-generated-59-million-in-total-mssp-savings-in-2021-3/ 2022-11-03T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareSignal-o3mBbg.jpeg https://medicaex.com/businesswire/pointclickcare-debuts-new-product-capabilities-and-solutions-at-connect-at-summit-2022-to-drive-deeper-insights-and-greater-collaboration-across-the-healthcare-continuum/ 2022-11-03T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/PointClickCareLogoCMYK-QM00n5.jpeg https://medicaex.com/businesswire/ur24technology-and-demetech-partner-to-combine-market-altering-innovation-with-renowned-leadership-in-surgical-products-and-global-distribution-2/ 2022-11-03T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo3-5jr8Jy.jpeg https://medicaex.com/businesswire/nine-healthcare-organizations-select-meditech-expanse-maas-platform-in-q3/ 2022-11-03T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/MEDITECH_Logo_28129-eDA0V5.jpeg https://medicaex.com/businesswire/exactech-to-showcase-new-innovations-at-aahks-2022-annual-meeting-booth-1101/ 2022-11-03T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/MicrosoftTeams-image_28529-cvy0vv.jpeg https://medicaex.com/businesswire/pavmed-to-hold-a-business-update-conference-call-and-webcast-on-november-15-2022/ 2022-11-03T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/PAVM_Logo-ufdM6C.jpeg https://medicaex.com/businesswire/acos-using-caresignals-deviceless-rpm-solution-generated-59-million-in-total-mssp-savings-in-2021-2/ 2022-11-03T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareSignal-xs4CL9.jpeg https://medicaex.com/businesswire/electromed-inc-to-participate-in-two-upcoming-investor-conferences/ 2022-11-03T13:12:08+00:00 https://medicaex.com/businesswire/ur24technology-and-demetech-partner-to-combine-market-altering-innovation-with-renowned-leadership-in-surgical-products-and-global-distribution/ 2022-11-03T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo3-D2mVSG.jpeg https://medicaex.com/businesswire/pfizers-elranatamab-granted-fda-breakthrough-therapy-designation-for-relapsed-or-refractory-multiple-myeloma/ 2022-11-03T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pfizer_Logo_Color_RGB_APPROVED-Qbzsbh.jpeg https://medicaex.com/businesswire/final-data-from-allovirs-phase-2-study-of-posoleucel-for-multi-virus-prevention-to-be-highlighted-in-oral-presentation-at-64th-american-society-of-hematology-annual-meeting/ 2022-11-03T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/AlloVir_Logo_FullColor5B25D-S0dlHf.jpeg https://medicaex.com/businesswire/gamida-cell-announces-omidubicel-data-to-be-presented-as-an-oral-presentation-at-64th-ash-annual-meeting/ 2022-11-03T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gamida-Cell-Logo_Sept2022-GUvhET.jpeg https://medicaex.com/businesswire/2seventy-bio-to-present-data-from-karmma-2-study-of-abecma-idecabtagene-vicleucel-at-the-64th-american-society-of-hematology-ash-annual-meeting-and-exposition/ 2022-11-03T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/2seventy_logo_for_BW-9gcBD3.jpeg https://medicaex.com/businesswire/prothena-to-present-data-on-survival-benefit-observed-in-completed-phase-3-study-of-drug-candidate-birtamimab-in-patients-with-mayo-stage-iv-al-amyloidosis-at-the-ash-2022-meeting/ 2022-11-03T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/prothena_logo_rgb-Uc1Srg.jpeg https://medicaex.com/businesswire/abridge-and-priority-health-partner-to-help-members-stay-on-top-of-their-health-and-deliver-improved-health-outcomes/ 2022-11-03T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Abridge_Priority_Image-GauamA.jpeg https://medicaex.com/businesswire/verisim-life-named-predictive-analytics-solution-of-the-year-by-biotech-breakthrough/ 2022-11-03T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/VeriSIM_Logo_FullColor_ExtraLarge_28129_28129-hxkW9Y.jpeg https://medicaex.com/businesswire/travelers-introduces-mental-health-app-for-injured-employees/ 2022-11-03T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/TravelersLogo-MazwL1.jpeg https://medicaex.com/businesswire/national-study-finds-conflicting-views-of-virtual-cares-promise-threatening-its-growth-high-optimism-investment-and-confusion/ 2022-11-03T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/omada_logo_horizontal-01-hHxCnl.jpeg https://medicaex.com/businesswire/acos-using-caresignals-deviceless-rpm-solution-generated-59-million-in-total-mssp-savings-in-2021/ 2022-11-03T13:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareSignal-Lb4KnK.jpeg https://medicaex.com/businesswire/ieso-selected-by-uk-department-of-international-trade-to-showcase-digital-mental-health-innovation-at-hlth-2022-2/ 2022-11-03T12:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ieso_Green_RGB-xnKkII.jpeg https://medicaex.com/businesswire/vizgen-wins-overall-biotech-company-of-the-year-in-2022-biotech-breakthrough-awards-program/ 2022-11-03T12:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/download-Jmp8Rg.jpeg https://medicaex.com/businesswire/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events-2/ 2022-11-03T12:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cybin_Primary_Logo_Blue_Final-LOBSsW.jpeg https://medicaex.com/businesswire/state-of-wisconsin-to-provide-access-to-prescription-digital-therapeutics-to-help-local-communities-fight-against-addiction-crisis-2/ 2022-11-03T12:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-Pear-Therapeutics-Final-yj7uHj.jpeg https://medicaex.com/businesswire/butterfly-network-reports-third-quarter-2022-financial-results-3/ 2022-11-03T12:12:16+00:00 https://medicaex.com/businesswire/butterfly-network-reports-third-quarter-2022-financial-results-2/ 2022-11-03T12:12:12+00:00 https://medicaex.com/businesswire/new-research-sheds-light-on-mental-health-crisis-around-pregnancy-2/ 2022-11-03T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Twill_Spacesuit_Orange-jEL8aN.jpeg https://medicaex.com/businesswire/transcarent-selects-prescryptive-health-to-power-a-new-different-and-better-integrated-pharmacy-experience-2/ 2022-11-03T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Transcarent_Experience_Different-QeilLA.jpeg https://medicaex.com/businesswire/senseonics-and-ascensia-announce-a-collaboration-with-the-nurse-practitioner-group-designed-to-expand-patient-access-by-providing-in-office-and-at-home-insertion-options-for-eversense-e3-continu-2/ 2022-11-03T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/SENS_logo-X0Dutj.jpeg https://medicaex.com/businesswire/investindustrial-creates-arterex-a-specialty-global-medical-device-contract-manufacturer-beginning-with-four-acquisitions-in-europe-and-north-america-2/ 2022-11-03T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/ii_logo_businesswire-XcMbs0.jpeg https://medicaex.com/businesswire/senseonics-and-ascensia-announce-a-collaboration-with-the-nurse-practitioner-group-designed-to-expand-patient-access-by-providing-in-office-and-at-home-insertion-options-for-eversense-e3-continu/ 2022-11-03T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/SENS_logo-AogCRA.jpeg https://medicaex.com/businesswire/butterfly-network-reports-third-quarter-2022-financial-results/ 2022-11-03T12:12:10+00:00 https://medicaex.com/businesswire/thermo-fisher-scientific-and-society-for-science-launch-junior-innovators-challenge-to-inspire-more-than-65000-future-stem-leaders-nationwide/ 2022-11-03T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/JIC_CMYK_-_Vertical_copy_002-3bkszv.jpeg https://medicaex.com/businesswire/kyocera-introduces-new-human-augmentation-technology-prototypes-in-japan-with-advanced-ai-to-enhance-human-abilities/ 2022-11-03T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/1_Mai_Logo-9q3Uyo.jpeg https://medicaex.com/businesswire/mojo-vision-announces-test-integration-with-alexa-shopping-list-on-smart-contact-lens/ 2022-11-03T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/MojoLens_AlexaClip22-wKEiQm.jpeg https://medicaex.com/businesswire/investindustrial-creates-arterex-a-specialty-global-medical-device-contract-manufacturer-beginning-with-four-acquisitions-in-europe-and-north-america/ 2022-11-03T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/ii_logo_businesswire-NhqDEe.jpeg https://medicaex.com/businesswire/organon-reports-results-for-the-third-quarter-ended-september-30-2022/ 2022-11-03T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Organon_Logo_RGB-tag-sUJzRe.jpeg https://medicaex.com/businesswire/ieso-selected-by-uk-department-of-international-trade-to-showcase-digital-mental-health-innovation-at-hlth-2022/ 2022-11-03T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ieso_Green_RGB-5hKjEc.jpeg https://medicaex.com/businesswire/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events/ 2022-11-03T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cybin_Primary_Logo_Blue_Final-XsRkoZ.jpeg https://medicaex.com/businesswire/state-of-wisconsin-to-provide-access-to-prescription-digital-therapeutics-to-help-local-communities-fight-against-addiction-crisis/ 2022-11-03T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-Pear-Therapeutics-Final-epgKHi.jpeg https://medicaex.com/businesswire/exelixis-and-catalent-enter-into-new-license-agreement-for-three-antibody-drug-conjugate-programs-with-the-potential-to-accelerate-exelixis-biologics-pipeline/ 2022-11-03T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/exelixis_id_rgb_2c-jnNOmY.jpeg https://medicaex.com/businesswire/global-gastrointestinal-diseases-therapeutics-research-market-report-2022-2026-new-product-launches-and-increasing-demand-for-biologics-targeted-therapies-researchandmarkets-com/ 2022-11-03T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Dm3ZSi.jpeg https://medicaex.com/businesswire/transcarent-selects-prescryptive-health-to-power-a-new-different-and-better-integrated-pharmacy-experience/ 2022-11-03T12:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Transcarent_Experience_Different-Tb3rJu.jpeg https://medicaex.com/businesswire/new-research-sheds-light-on-mental-health-crisis-around-pregnancy/ 2022-11-03T12:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/11/Twill_Spacesuit_Orange-kvwLY0.jpeg https://medicaex.com/businesswire/zoetis-announces-third-quarter-2022-results-3/ 2022-11-03T11:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Zoetis_c-raHr2T.jpeg https://medicaex.com/businesswire/spectrum-pharmaceuticals-to-report-third-quarter-2022-financial-results-and-provide-corporate-update-2/ 2022-11-03T11:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/NEW_Logo_Spectrum-V72Cs8.jpeg https://medicaex.com/businesswire/teva-reports-third-quarter-2022-financial-results-2/ 2022-11-03T11:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Infographic_Q3_2022_FINAL-rY5rDp.jpeg https://medicaex.com/businesswire/virios-therapeutics-to-report-third-quarter-2022-financial-results-and-provide-corporate-update-on-monday-november-14-2022-2/ 2022-11-03T11:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/Virios_Logo_Blue-YHc6eX.jpeg https://medicaex.com/businesswire/ironwood-pharmaceuticals-reports-strong-third-quarter-2022-results-maintains-full-year-2022-financial-guidance-2/ 2022-11-03T11:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/IRWD_Logo_Color_Vertical_RD_RGB-VIBAJj.jpeg https://medicaex.com/businesswire/elucid-appoints-dr-michael-lesh-to-board-of-directors-2/ 2022-11-03T11:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lesh_Head-GOTj4R.jpeg https://medicaex.com/businesswire/exscientia-expands-biologics-design-capability-with-automated-laboratory/ 2022-11-03T11:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Exscientia_Logo-ZnpYzq.jpeg https://medicaex.com/businesswire/new-report-from-goodrx-shows-positive-impact-of-giving-pharmacists-the-power-to-prescribe/ 2022-11-03T11:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/GoodRx_logo_28229-fT4eNZ.jpeg https://medicaex.com/businesswire/orthofix-reports-third-quarter-2022-results-2/ 2022-11-03T11:12:12+00:00 https://medicaex.com/businesswire/profound-improvement-for-pancreatic-cancer-patients-using-civasheet-a-new-radiation-device/ 2022-11-03T11:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/CivaSheet_Pancreas_Graph-Y5tm6h.jpeg https://medicaex.com/businesswire/elucid-appoints-dr-michael-lesh-to-board-of-directors/ 2022-11-03T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lesh_Head-Joc9OC.jpeg https://medicaex.com/businesswire/cardiovascular-systems-inc-reports-fiscal-2023-first-quarter-financial-results-2/ 2022-11-03T11:12:11+00:00 https://medicaex.com/businesswire/bruker-reports-third-quarter-2022-financial-results/ 2022-11-03T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bruker_logo-JowKVA.jpeg https://medicaex.com/businesswire/cardiovascular-systems-inc-reports-fiscal-2023-first-quarter-financial-results/ 2022-11-03T11:12:08+00:00 https://medicaex.com/businesswire/orthofix-reports-third-quarter-2022-results/ 2022-11-03T11:12:08+00:00 https://medicaex.com/businesswire/infusystem-and-sanara-medtech-announce-wound-therapy-partnership/ 2022-11-03T11:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/InfuSystem_SAFE.SMART_.TRUSTED._PMSC_Stacked_10-19-eYZq0l.jpeg https://medicaex.com/businesswire/zoetis-announces-third-quarter-2022-results/ 2022-11-03T11:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Zoetis_c-cRPzUH.jpeg https://medicaex.com/businesswire/spectrum-pharmaceuticals-to-report-third-quarter-2022-financial-results-and-provide-corporate-update/ 2022-11-03T11:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/NEW_Logo_Spectrum-cAvRVY.jpeg https://medicaex.com/businesswire/teva-reports-third-quarter-2022-financial-results/ 2022-11-03T11:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Infographic_Q3_2022_FINAL-XtjbYv.jpeg https://medicaex.com/businesswire/virios-therapeutics-to-report-third-quarter-2022-financial-results-and-provide-corporate-update-on-monday-november-14-2022/ 2022-11-03T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Virios_Logo_Blue-bEdJ2R.jpeg https://medicaex.com/businesswire/ironwood-pharmaceuticals-reports-strong-third-quarter-2022-results-maintains-full-year-2022-financial-guidance/ 2022-11-03T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/IRWD_Logo_Color_Vertical_RD_RGB-0lt7WK.jpeg https://medicaex.com/businesswire/aurinia-reports-third-quarter-and-nine-months-2022-financial-and-operational-results-2/ 2022-11-03T10:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/aurina_logo-rO0xSS.jpeg https://medicaex.com/businesswire/modivcare-reports-third-quarter-2022-financial-results-and-updates-2022-guidance/ 2022-11-03T10:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Modivcare_Primary-1200x600-903638b-eQ4Nee.jpeg https://medicaex.com/businesswire/cardior-appoints-axel-sven-malkomes-as-chief-financial-officer/ 2022-11-03T10:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-cardior-mesh-green-RGB_300dpi-R6hJBv.jpeg https://medicaex.com/businesswire/latest-process-validation-guidance-requirements-course-fda-and-eu-annex-15-qualifications-and-validation-november-7-8-2022-researchandmarkets-com/ 2022-11-03T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-NpFTKn.jpeg https://medicaex.com/businesswire/aurinia-reports-third-quarter-and-nine-months-2022-financial-and-operational-results/ 2022-11-03T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/aurina_logo-hLZgQy.jpeg https://medicaex.com/businesswire/sia-partners-accelerates-in-the-life-sciences-sector-with-the-acquisition-of-latham-biopharm-group-3/ 2022-11-03T09:13:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/FINAL_LOGO_2020-01_28129-6XvavC.jpeg https://medicaex.com/businesswire/sia-partners-accelerates-in-the-life-sciences-sector-with-the-acquisition-of-latham-biopharm-group-2/ 2022-11-03T09:13:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/FINAL_LOGO_2020-01_28129-YjYqw2.jpeg https://medicaex.com/businesswire/sia-partners-accelerates-in-the-life-sciences-sector-with-the-acquisition-of-latham-biopharm-group/ 2022-11-03T09:13:00+00:00 https://medicaex.com/wp-content/uploads/2022/11/FINAL_LOGO_2020-01_28129-az1FNK.jpeg https://medicaex.com/businesswire/seven-pharma-ceos-announce-new-joint-action-to-accelerate-net-zero-healthcare-3/ 2022-11-03T07:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/SMI_TCColourSM-CP84ys.jpeg https://medicaex.com/businesswire/seven-pharma-ceos-announce-new-joint-action-to-accelerate-net-zero-healthcare-2/ 2022-11-03T07:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/SMI_TCColourSM-rc2FH5.jpeg https://medicaex.com/businesswire/seven-pharma-ceos-announce-new-joint-action-to-accelerate-net-zero-healthcare/ 2022-11-03T07:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/SMI_TCColourSM-VAjeRv.jpeg https://medicaex.com/businesswire/fortive-to-present-at-the-baird-global-industrial-conference/ 2022-11-03T00:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Fortive_Logo-aQC7Pg.jpeg https://medicaex.com/businesswire/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-2/ 2022-11-02T22:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/4357884cpuma_logo_JPEG-EnzBGb.jpeg https://medicaex.com/businesswire/bluebird-bio-to-present-at-the-31st-annual-credit-suisse-healthcare-conference-2/ 2022-11-02T22:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Full_Color_Logo_Bluebird-Logo-full-color-Fa84W5.jpeg https://medicaex.com/businesswire/tricida-provides-strategic-update-2/ 2022-11-02T22:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tricida_Logo-vector-alt.clr_current_colors_092518-ElX2qj.jpeg https://medicaex.com/businesswire/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4/ 2022-11-02T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/4357884cpuma_logo_JPEG-cUubDS.jpeg https://medicaex.com/businesswire/elevance-health-announces-appearance-at-4th-annual-wolfe-research-healthcare-conference-2/ 2022-11-02T21:12:12+00:00 https://medicaex.com/businesswire/infusystem-to-report-third-quarter-2022-financial-results-on-november-8-2022-2/ 2022-11-02T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/InfuSystem_SAFE.SMART_.TRUSTED._PMSC_Stacked_10-19-1jRfQ5.jpeg https://medicaex.com/businesswire/infusystem-to-report-third-quarter-2022-financial-results-on-november-8-2022/ 2022-11-02T21:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/InfuSystem_SAFE.SMART_.TRUSTED._PMSC_Stacked_10-19-QXwNzr.jpeg https://medicaex.com/businesswire/icon-reports-third-quarter-2022-results/ 2022-11-02T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/ICON_Positive_logo_PNG_28nostrap29-XRuYmh.jpeg https://medicaex.com/businesswire/tricida-provides-strategic-update/ 2022-11-02T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tricida_Logo-vector-alt.clr_current_colors_092518-tSVy26.jpeg https://medicaex.com/businesswire/elevance-health-announces-appearance-at-4th-annual-wolfe-research-healthcare-conference/ 2022-11-02T21:12:02+00:00 https://medicaex.com/businesswire/vapotherm-reports-third-quarter-2022-financial-results-3/ 2022-11-02T20:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/VAPO_Logo-zKyFgh.jpeg https://medicaex.com/businesswire/veracyte-announces-third-quarter-2022-financial-results-3/ 2022-11-02T20:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Veracyte_RGB_LRG_H_registered-bsg5W5.jpeg https://medicaex.com/businesswire/glaukos-corporation-announces-third-quarter-2022-financial-results-2/ 2022-11-02T20:12:18+00:00 https://medicaex.com/businesswire/acadia-pharmaceuticals-reports-third-quarter-2022-financial-results-2/ 2022-11-02T20:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Acadia_new_logo_2020-DAPmE4.jpeg https://medicaex.com/businesswire/igm-biosciences-and-adc-therapeutics-announce-clinical-collaboration-agreement-to-evaluate-imvotamab-igm-2323-in-combination-with-zynlonta-in-patients-with-relapsed-or-refractory-b-cell-non-ho-2/ 2022-11-02T20:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/ADCT_4C_TM-mEc4sz.jpeg https://medicaex.com/businesswire/tandem-diabetes-care-announces-third-quarter-2022-financial-results-and-updated-full-year-2022-financial-guidance-2/ 2022-11-02T20:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/2022_02_01_Tandem_Horizontal_Logo_New_RGB-SNYJ4k.jpeg https://medicaex.com/businesswire/quidelortho-reports-third-quarter-2022-financial-results-3/ 2022-11-02T20:12:15+00:00 https://medicaex.com/businesswire/personalis-reports-third-quarter-2022-financial-results/ 2022-11-02T20:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/PersonalisLogo-RGB-no-tagline-g0qV8P.jpeg https://medicaex.com/businesswire/veracyte-announces-third-quarter-2022-financial-results-2/ 2022-11-02T20:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Veracyte_RGB_LRG_H_registered-5dfpvR.jpeg https://medicaex.com/businesswire/staar-surgical-reports-third-quarter-net-sales-of-76-million-up-30-y-y-2/ 2022-11-02T20:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/STAAR_Surgical_Logo_Primary_Lockup_28Sunise_Teal29-yVEeH5.jpeg https://medicaex.com/businesswire/tandem-diabetes-care-announces-third-quarter-2022-financial-results-and-updated-full-year-2022-financial-guidance/ 2022-11-02T20:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/2022_02_01_Tandem_Horizontal_Logo_New_RGB-5efaXl.jpeg https://medicaex.com/businesswire/quidelortho-reports-third-quarter-2022-financial-results-2/ 2022-11-02T20:12:12+00:00 https://medicaex.com/businesswire/vapotherm-reports-third-quarter-2022-financial-results-2/ 2022-11-02T20:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/VAPO_Logo-keY2gh.jpeg https://medicaex.com/businesswire/vapotherm-reports-third-quarter-2022-financial-results/ 2022-11-02T20:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/VAPO_Logo-86zljr.jpeg https://medicaex.com/businesswire/quidelortho-reports-third-quarter-2022-financial-results/ 2022-11-02T20:12:09+00:00 https://medicaex.com/businesswire/staar-surgical-reports-third-quarter-net-sales-of-76-million-up-30-y-y/ 2022-11-02T20:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/STAAR_Surgical_Logo_Primary_Lockup_28Sunise_Teal29-qskbNl.jpeg https://medicaex.com/businesswire/glaukos-corporation-announces-third-quarter-2022-financial-results/ 2022-11-02T20:12:06+00:00 https://medicaex.com/businesswire/acadia-pharmaceuticals-reports-third-quarter-2022-financial-results/ 2022-11-02T20:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Acadia_new_logo_2020-4noJXI.jpeg https://medicaex.com/businesswire/igm-biosciences-and-adc-therapeutics-announce-clinical-collaboration-agreement-to-evaluate-imvotamab-igm-2323-in-combination-with-zynlonta-in-patients-with-relapsed-or-refractory-b-cell-non-ho/ 2022-11-02T20:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/ADCT_4C_TM-x6eNns.jpeg https://medicaex.com/businesswire/bluebird-bio-to-present-at-the-31st-annual-credit-suisse-healthcare-conference/ 2022-11-02T20:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Full_Color_Logo_Bluebird-Logo-full-color-sBd4J8.jpeg https://medicaex.com/businesswire/veracyte-announces-third-quarter-2022-financial-results/ 2022-11-02T20:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Veracyte_RGB_LRG_H_registered-Btmm4C.jpeg https://medicaex.com/businesswire/the-access-to-advanced-health-institute-develops-longer-lasting-and-broadly-protective-sars-cov-2-rna-vaccine-candidate-that-is-stable-at-room-temperature-2/ 2022-11-02T19:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/AAHI_BrandAssets_PhotonFactory_20211201_AAHI_Logo_Color-Q2SqXl.jpeg https://medicaex.com/businesswire/cerus-corporation-announces-award-of-u-s-department-of-defense-funding-for-development-of-pathogen-reduced-lyophilized-cryoprecipitate-3/ 2022-11-02T19:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/cerus_210x60-9791Rt.jpeg https://medicaex.com/businesswire/global-orthopedic-prosthetics-market-report-2022-to-2031-featuring-blatchford-zimmer-biomet-depuy-synthes-and-stryker-among-others-researchandmarkets-com-2/ 2022-11-02T19:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-QYEdhM.jpeg https://medicaex.com/businesswire/solesis-expands-film-and-coating-capabilities-with-acquisition-of-polyzen-2/ 2022-11-02T19:12:12+00:00 https://medicaex.com/businesswire/solesis-acquires-polyzen-expanding-film-and-coating-capabilities-3/ 2022-11-02T19:12:12+00:00 https://medicaex.com/businesswire/global-healthcare-middleware-market-2022-2026-rising-amount-of-healthcare-data-increasing-adoption-of-ehrs-and-growing-demand-from-healthcare-providers-driving-sector-researchandmarkets-com/ 2022-11-02T19:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-CNDTgx.jpeg https://medicaex.com/businesswire/early-is-good-raises-4-million-seed-round-from-social-capital/ 2022-11-02T19:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/eig_logo-DPjxIt.jpeg https://medicaex.com/businesswire/solesis-expands-film-and-coating-capabilities-with-acquisition-of-polyzen/ 2022-11-02T19:12:09+00:00 https://medicaex.com/businesswire/solesis-acquires-polyzen-expanding-film-and-coating-capabilities-2/ 2022-11-02T19:12:09+00:00 https://medicaex.com/businesswire/global-orthopedic-prosthetics-market-report-2022-to-2031-featuring-blatchford-zimmer-biomet-depuy-synthes-and-stryker-among-others-researchandmarkets-com/ 2022-11-02T19:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-MLlIM6.jpeg https://medicaex.com/businesswire/cerus-corporation-announces-award-of-u-s-department-of-defense-funding-for-development-of-pathogen-reduced-lyophilized-cryoprecipitate-2/ 2022-11-02T19:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/cerus_210x60-FAsxt2.jpeg https://medicaex.com/businesswire/solesis-acquires-polyzen-expanding-film-and-coating-capabilities/ 2022-11-02T19:12:06+00:00 https://medicaex.com/businesswire/the-access-to-advanced-health-institute-develops-longer-lasting-and-broadly-protective-sars-cov-2-rna-vaccine-candidate-that-is-stable-at-room-temperature/ 2022-11-02T19:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/AAHI_BrandAssets_PhotonFactory_20211201_AAHI_Logo_Color-arWriN.jpeg https://medicaex.com/businesswire/cerus-corporation-announces-award-of-u-s-department-of-defense-funding-for-development-of-pathogen-reduced-lyophilized-cryoprecipitate/ 2022-11-02T19:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/cerus_210x60-fkvC0B.jpeg https://medicaex.com/businesswire/insights-on-the-heart-failure-therapeutics-global-market-to-2027-innovations-and-development-in-the-heart-failure-therapeutics-presents-opportunities-researchandmarkets-com/ 2022-11-02T19:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-5bCb7O.jpeg https://medicaex.com/businesswire/acute-bacterial-skin-and-skin-structure-infections-global-market-report-2022-acquisition-of-drug-distribution-rights-a-key-growth-factor-researchandmarkets-com/ 2022-11-02T19:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-wkyuC1.jpeg https://medicaex.com/businesswire/85-of-us-er-doctors-report-increase-in-rsv-cases-in-past-two-weeks-says-wave-1-of-incrowd-rsv-tracking-report-2/ 2022-11-02T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/InCrowd-pale-matching-yellow_300dpi_resaved_12-14-16-3xUrws.jpeg https://medicaex.com/businesswire/transgene-announces-positive-interim-analysis-results-of-phase-ii-trial-evaluating-tg4001-avelumab-vs-avelumab-in-hpv-positive-anogenital-cancers-2/ 2022-11-02T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Transgene-hr0vwH.jpeg https://medicaex.com/businesswire/asia-pacific-dna-sequencing-market-report-2022-significant-technological-advancements-the-growth-of-large-scale-sequencing-initiatives-and-support-by-major-governments-driving-sector-researchandma-2/ 2022-11-02T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-YsoBAC.jpeg https://medicaex.com/businesswire/asia-pacific-dna-sequencing-market-report-2022-significant-technological-advancements-the-growth-of-large-scale-sequencing-initiatives-and-support-by-major-governments-driving-sector-researchandma/ 2022-11-02T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ENB5l2.jpeg https://medicaex.com/businesswire/bayer-to-highlight-additional-analyses-from-comprehensive-kerendia-finerenone-clinical-trial-program-at-the-american-society-of-nephrologys-2022-kidney-week/ 2022-11-02T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bayer_Logo-RYzwgd.jpeg https://medicaex.com/businesswire/85-of-us-er-doctors-report-increase-in-rsv-cases-in-past-two-weeks-says-wave-1-of-incrowd-rsv-tracking-report/ 2022-11-02T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/InCrowd-pale-matching-yellow_300dpi_resaved_12-14-16-sAo9Eb.jpeg https://medicaex.com/businesswire/transgene-announces-positive-interim-analysis-results-of-phase-ii-trial-evaluating-tg4001-avelumab-vs-avelumab-in-hpv-positive-anogenital-cancers/ 2022-11-02T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Transgene-OxUCqz.jpeg https://medicaex.com/businesswire/europe-branded-generics-market-report-2022-rise-in-government-initiatives-for-promoting-branded-generics-driving-growth-researchandmarkets-com/ 2022-11-02T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-YQrZDb.jpeg https://medicaex.com/businesswire/revitalist-releases-supplement-line-to-enhance-the-results-of-psychedelic-medicines-2/ 2022-11-02T16:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Revitalist_text_logo-2-4jqYeT.jpeg https://medicaex.com/businesswire/microfluidics-global-market-report-2022-rising-demand-for-advanced-and-better-point-of-care-testing-driving-growth-researchandmarkets-com-2/ 2022-11-02T16:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-V1zXAQ.jpeg https://medicaex.com/businesswire/healthcare-mobility-solutions-growth-opportunities-artificial-intelligence-the-internet-of-things-and-blockchain-technology-improve-hospital-communications-and-patient-data-security-researchandma-2/ 2022-11-02T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-TgYv8L.jpeg https://medicaex.com/businesswire/global-medical-device-reprocessing-market-report-2022-need-to-reduce-medical-waste-driving-growth-researchandmarkets-com/ 2022-11-02T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-PAp68c.jpeg https://medicaex.com/businesswire/systemone-launches-multi-instrument-medical-diagnostic-network-in-tanzania-2/ 2022-11-02T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/PathTrueNatImage-4tkgrB.jpeg https://medicaex.com/businesswire/microfluidics-global-market-report-2022-rising-demand-for-advanced-and-better-point-of-care-testing-driving-growth-researchandmarkets-com/ 2022-11-02T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-MhfWDZ.jpeg https://medicaex.com/businesswire/united-states-vaccine-market-analysis-report-2022-approval-of-pediatric-vaccinations-and-universal-vaccine-trials-have-significantly-contributed-to-market-expansion-researchandmarkets-com/ 2022-11-02T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-NbuGVT.jpeg https://medicaex.com/businesswire/revitalist-releases-supplement-line-to-enhance-the-results-of-psychedelic-medicines/ 2022-11-02T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Revitalist_text_logo-2-UfHDVo.jpeg https://medicaex.com/businesswire/asia-pacific-human-papillomavirus-vaccine-market-report-2022-growing-number-of-hpv-awareness-programs-presents-opportunities-for-growth-researchandmarkets-com/ 2022-11-02T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-JbsWDO.jpeg https://medicaex.com/businesswire/healthcare-mobility-solutions-growth-opportunities-artificial-intelligence-the-internet-of-things-and-blockchain-technology-improve-hospital-communications-and-patient-data-security-researchandma/ 2022-11-02T16:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Txl9D7.jpeg https://medicaex.com/businesswire/systemone-launches-multi-instrument-medical-diagnostic-network-in-tanzania/ 2022-11-02T16:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/PathTrueNatImage-KlaZ7P.jpeg https://medicaex.com/businesswire/healthvana-passes-50-million-health-records-delivered-across-the-united-states/ 2022-11-02T16:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/11/1st_image_under_Key_HIV_and_Sexual_Health_Outcomes-MePWBP.jpeg https://medicaex.com/businesswire/earlier-predictions-in-covid-19-infection-rates-with-wearable-device-data-and-careevolutions-research-platform-3/ 2022-11-02T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareEvolutionLogo_2c_28229-LAJcWp.jpeg